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Abstract
Objective: Evaluate the feasibility and potential impacts on hand function using a wearable stimulation device
(the VTS Glove) which provides mechanical, vibratory input to the affected limb of chronic stroke survivors.
Methods: A double-blind, randomized, controlled feasibility study including sixteen chronic stroke survivors
(mean age: 54; 1-13 years post-stroke) with diminished movement and tactile perception in their affected
hand. Participants were given a wearable device to take home and asked to wear it for three hours daily over
eight weeks. The device intervention was either (1) the VTS Glove, which provided vibrotactile stimulation to
the hand, or (2) an identical glove with vibration disabled. Participants were equally randomly assigned to each
condition. Hand and arm function were measured weekly at home and in local physical therapy clinics.
Results: Participants using the VTS Glove showed significantly improved Semmes-Weinstein monofilament
exam, reduction in Modified Ashworth measures in the fingers, and some increased voluntary finger flexion,
elbow and shoulder range of motion.
Conclusions: Vibrotactile stimulation applied to the disabled limb may impact tactile perception, tone and
spasticity, and voluntary range of motion. Wearable devices allow extended application and study of
stimulation methods outside of a clinical setting.
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Background
Over 15 million people have a stroke each year, making
it one of the leading causes of disability in the United
States and worldwide [1, 2, 3]. Upper limb disability
occurs in about 50% of cases [4, 5] and diminished tac-
tile perception in about 35-55% [6, 7]. Current meth-
ods of therapy for upper limb dysfunction after stroke
focus on activities which use the limb; however, these
forms of rehabilitation are not accessible to survivors
with very limited function.
Somatosensory stimulation may be an effective and
accessible modality for rehabilitation. Most fundamen-
tally, somatosensory input is known to drive cortical
organization and skill acquisition [8, 9, 10]. Somatosen-
sory input has also been associated with sensorimotor
recovery after CNS injury in animal [11, 12] as well
as human studies [13]. Afferent input is also integral
to limb use. Tactile perception and proprioception are
*Correspondence: cseim@stanford.edu
1 Stanford University, Department of Mechanical Engineering, Stanford,
CA, USA
Full list of author information is available at the end of the article
Figure 1 The computerized glove that provides vibrotactile
stimulation for this study.
factors in motor performance and are thought to co-
activate with motorcortical circuits [14, 15, 16].
Afferent electrical stimulation has been studied as
a means for providing sensory input to the disabled
extremity of stroke survivors [17, 18, 19, 20, 21], and
preliminary evidence shows changes in tactile percep-
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tion, motor function and brain activity. Mechanical, vi-
bratory stimulation can be applied without the place-
ment, electrodes or gel of electrical stimulation. Affer-
ent electrical stimulation most often targets cutaneous
sensory receptors in the skin; while vibrotactile stim-
ulation can activate both muscle afferent fibers and
cutaneous sensory receptors without inducing move-
ment. Vibrotactile stimulation has been coupled with
other methods such as robotic manipulation or mu-
sic practice exercises for rehabilitation [22, 23], and
applied to the arm for in-situ dexterity improvement
[24]. Improved spasticity and significant neuromuscu-
lar changes have been found in laboratory studies of
whole-body vibration (WBV) [25, 26, 27, 28] and focal
muscle/tendon vibration [29, 30, 31, 32, 33, 34, 35].
Despite encouraging data, vibrotactile stimulation
is not widely used outside the clinic because there
are no mobile devices that can deliver and study this
form of mechanical stimulation for prolonged periods
of time. Here we designed a lightweight, wireless, wear-
able device to apply vibrotactile stimulation to the
hand. Wearable devices are closely coupled with the
body, and thus allow stimulation for extended periods
of time and in the background of daily life. The inter-
vention is mobile and simple to apply without access to
a clinic. Users simply wear the device, requiring little
exertion and time, which may facilitate adherence. The
device was deployed in a controlled feasibility trial of
chronic stroke survivors with upper limb sensorimotor
deficits. If wearable stimulation proves to be effective
it could directly impact healthcare delivery, because it
may provide a mobile, affordable rehabilitation option
for patients who otherwise would not have access to
high intensity stroke rehabilitation.
Methods
The study was a double-blind, randomized controlled
study performed in Atlanta, Georgia. Eligible partici-
pants were randomly assigned to the vibrotactile stim-
ulation glove (VTS) or sham control glove (control)
condition. All were asked to wear the device on their
affected hand for three hours each day for eight weeks.
As a feasibility study, the trial was not listed with clin-
icaltrials.gov but was approved and overseen by the
Office of Research Integrity’s IRB board of Georgia
Institute of Technology. All participants were screened
using the Mini Mental State Exam (MMSE) and pro-
vided written consent before beginning the study.
Participants
The study included 16 chronic stroke survivors with
upper extremity deficits (ages 28-68; 1-13 years post
stroke (Mean=3.7, SD=3.3); 8 VTS condition/8 con-
trol condition). Participants were recruited through
stroke support groups in the Atlanta metropolitan
area. Figure 2 shows a breakdown of participant demo-
graphics. Individuals with various levels of arm func-
tion could participate. The protocol requires no exer-
cises and thus is accessible to patients with very lim-
ited movement. Because this investigation is prelimi-
nary, no prior data are available for optimal sample
size calculation.
Inclusion criteria:
• History of stroke >1 year prior
• Impaired touch sensation in the hand (Semmes-
Weinstein monofilament exam score of ≥ 0.2
grams on 3 of 20 measured locations on the hand)
• Passive range of motion allows user to don a glove
• English speaker, age 18+
Exclusion criteria:
• Intact sensation in the hand (determined by
Semmes-Weinstein monofilament exam)
• Active Range of Motion within normal limits for
all joints of the fingers
• Cognitive deficits, dementia or aphasia (MMSE
score of <22) that prevent informed consent
• Other neurological condition that may affect mo-
tor response (e.g. Parkinson’s, ALS, MS)
• Pain in the limb that substantially interferes with
ADLs or prior arm injury
• Enrollment in a conflicting study, Botox treat-
ment, or other upper extremity rehabilitation pro-
gram during the study period
Study Design
The study consisted of eight weeks using the stimu-
lation or sham device during daily life. Participants
wore the glove daily and met with blinded study ad-
ministrators for weekly visits to measure sensorimotor
function.
At the first visit, all participants received a device,
cord and safety manual to take with them. Participants
were instructed to wear the device, turned on, for
three hours every day while awake. Users were no-
tified that an onboard measurement unit would track
usage time, and that 21 hours of weekly use is required.
All participants were advised to charge the glove each
night using the cord provided, just as one might do
with a cell phone. Then, wear the device on-the-go or
at home during their normal routine. Wearing did not
need to be continuous each day, but had to total three
hours. The dosage was chosen to be intensive, while
not too much daily commitment for participants.
Seim et al. Page 3 of 10
Figure 2 Demographics and notes for participants in the study. The experimental VTS group includes participants 1-8, and the
sham control group includes participants 9-16. These participant numbers were assigned only to present data in this manuscript.
Apparatus
A wearable computing glove was designed to pro-
vide vibrotactile stimulation to participants through-
out their daily life (Figure 1). It can be taken home
and used outside of the clinic environment. Addition-
ally, the glove is worn while users conduct their daily
life – making the rehabilitation low-effort and “pas-
sive.”
Wearable Device
The wearable device (“VTS Glove”) is designed to be
low-cost, lightweight, and mobile. The device is a fin-
gerless glove with a vibration motor attached to each
dorsal phalanx. This design allows a designated actua-
tor for each finger, while stimulating a region where
vibrations can reach the glabrous skin of the palm
and the finger extensor tendons. The heart of the de-
vice is a circuit board and microcontroller, which ac-
tivates these motors in a pre-programmed sequence
when the switch is turned “on.” The onboard gyro-
scope logs movement data along with usage data onto
a microSD card which is checked by proctors for proto-
col adherence each week. The glove is rechargeable and
has a battery life that allows wireless stimulation for
four hours between charges. Design and implementa-
tion of the device is reported in detail in a companion
manuscript [36].
Stimulus Design
For this experiment, stimulation characteristics were
designed to target cutaneous mechanoreceptors –
specifically the Pacinian corpuscles – which respond
to direct vibration and vibration transmitted through
the body at a frequency range of 10-400 Hz (preferen-
tially responding around 250 Hz) [37]. Stimulation pat-
tern and timing was designed to be intensive but not
uncomfortable by using many vibration pulses with a
changing location across the fingers.
Small, coin-shaped vibration motors from Precision
Microdrives (ERM-type, Model #310-113) provide the
stimulation for this experiment. These motors were
driven at a voltage of 3.3V for an approximate am-
plitude of 1.5 g and 210 Hz vibration frequency (mea-
sured in a laboratory setting for validation at 1.3 g
and 175 Hz when attached to the glove). Two stim-
ulation sequences were used, each based on the fin-
ger pattern for a piano song. Song patterns provided
a framework for pseudo-random stimulation and the
option to later combine stimulation with music prac-
tice exercises for a lighthearted therapy routine. Each
song pattern (Ode to Joy and Happy Birthday) was
extended with a short sequence to balance stimulation
evenly across all fingers. During each repetition the
pattern played once quickly (250 ms vibrations, 100
ms pause between each stimulus) and once slowly (700
ms vibrations, 100 ms pauses). These songs were cho-
sen for their recognizable, one-handed melodies with
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5-7 notes which could be played on the keyboard with
little-to-no hand shifting. The stimulation pattern was
switched weekly, alternating between the two “songs.”
Conditions
Participants continued their standard of care, and
none were enrolled in concurrent upper limb rehabili-
tation programs.
Intervention Condition
Participants in the vibrotactile stimulation (VTS) con-
dition received a glove with vibration enabled. The
protocol used here includes no required exercises. Par-
ticipants were asked to wear their glove, switched on
(so the indicator light appears), for three hours daily
while awake. Users should also charge the battery each
night and as needed.
Control Condition
Participants in the sham control condition receive a
glove with vibration disabled. The appearance of the
device was the same as the experimental condition. All
indicator lights on the computer board activate in the
same fashion. Instructions and language also matched
those in the VTS condition: wear the glove on their
affected hand, switched on, for three hours daily while
awake, and charge the battery each night.
The control condition was assigned a sham device
(rather than no intervention) to examine the tolerance
of the wearable device with and without stimulation,
evaluate if the vibrotactile stimulation itself may have
an impact on measures, and provide some data on
mechanisms underlying this technique by comparing
the conditions.
Outcome measures
Baseline demographic information collected was sex,
age, date of stroke, type of stroke, and side affected.
Measurements are taken during weekly visits through-
out the study. Visits occur at the patient’s home or
a midway meeting spot. All measures were performed
by trained proctors not involved in the intervention or
data analysis. For all participants, key measurements
were taken by a blinded occupational therapist. Those
measures were taken at the beginning (day 0), mid-
dle (4 weeks), and end (8 weeks) of the study. The
therapist and study proctor for each participant was
consistent to minimize inter-rater variability.
The intent of this study was to examine the ini-
tial feasibility in this device and technique. Thus, data
on engineering, design, comfort and usability was col-
lected through weekly surveys and observations. En-
gineering data are presented in another manuscript
along with subsequent design work [36]. While here
we provide data on measures of arm function.
Figure 3 Semmes-Weinstein Monofilament Exam results by
group at baseline and eight weeks. This graph shows the
group’s average sum of perceived forces across 20 locations on
the hand. Smaller perceived forces equate to greater tactile
perception. Logarithmic scale used to render all force levels.
Primary Outcome Measures
The Semmes-Weinstein Monofilament Exam (SWME)
is used to assess cutaneous tactile perception in the
affected hand. Locations on the dorsal and volar side
of the hand are assessed, including the fingers. This
test has good intra-rater reliability and requires little
training. This assessment was done weekly.
Secondary Outcome Measures
The Modified Ashworth Scale (MAS) is used to assess
resistance to passive motion from involuntary muscle
tone and spasticity [1]. In this study, MAS was mea-
sured for flexion and extension of the fingers, thumb,
wrist, elbow and shoulder of the participant’s affected
upper limb. Confounding factors for this measure were
controlled whenever possible including: time of day,
time after medication dosage, arm position, and rater.
Voluntary angular range of motion (Active Range of
Motion (AROM)) is used to assess motor impairment.
Here, these measures were made for flexion and exten-
sion of the fingers, wrist, elbow and shoulder of the
participant’s affected upper limb. This measure can
capture changes in function when participant dexter-
ity is too low to perform tests like the Jebsen-Taylor.
A trained occupational therapist performed all move-
ment and spasticity measures in a clinical setting at
the beginning, middle and end of the study. Each week,
participants are also given a worksheet to report what
they did while wearing the device, observations, or
comments about the device.
[1]hypertonicity, spasticity, and resulting involuntary
muscle tone
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Figure 4 Trajectory of Semmes-Weinstein Monofilament
Exam results over eight weeks for both conditions. This graph
shows the group’s average sum of perceived forces across 20
locations on the hand. Smaller perceived force values equate
to greater tactile perception. Logarithmic scale used to render
all force levels.
Data analysis
Using an intention-to-treat analysis, we processed data
for all participants including two who had to with-
draw prematurely due to unrelated circumstances. The
last measured values were used for the determination
of any missing values in the case of dropouts or a
missed visit, conservatively assuming that no changes
occurred since the last measure. Paired observations
were compared using the Wilcoxon signed-ranks test,
and measures between groups were compared using the
Mann–Whitney U test. A p-value <0.05 was consid-
ered statistically significant.
Results
Adherence for users in both conditions was measured
each week using self-reported usage times matched
with data from the glove’s inertial measurement unit.
If usage time had not been within three hours of the
required weekly time (21 hours) for two consecutive
weeks, the participant would have been released from
the study. No such occurrences happened during the
trial.
Semmes-Weinstein Monofilament Exam (SWME)
This measure was taken at 20 points on the hand –
yielding one minimum perceivable force value per lo-
cation. Each filament represents a level of force, but the
Semmes-Weinstein exam filaments are not equidistant
(i.e. 2 grams, 4 grams, and 400 grams are sequential
ratings). For this reason, a weighted sum or weighted
average is calculated, to compare the sensitivity of the
hand as a whole (20 points measured). A minimum
sum of 1.4 grams corresponding to “normal” sensa-
tion at all points and a maximum sum of 6000 grams
corresponding to only “deep pressure sensation” at all
points. These sums were divided by 20 to calculate the
average perceivable force across the hand. Smaller per-
ceived forces equate to better tactile perception. One
participant in the VTS condition is not included in
these calculations because their starting measures pre-
vent representation on the graphs. This user initially
presented as insensate at all points, but could accu-
rately report deep pressure sensation at three points
later in the study.
Starting means[2] (M=832.4 grams, SD=1206 for
VTS; M=501.6 grams, SD=949.7 for control) were
compared using Mann–Whitney U test (U=18; z=-
1.10; p=0.271). Baseline measures of the VTS exper-
imental group were compared to measures at eight
weeks (M=9.701 grams, SD=14.25) and results suggest
that there is a significant difference (t-test: t(6)=-3.50;
p=0.006; signed-ranks: Z=-1.89; p<0.05). As figure 3
shows, the VTS condition is able to sense smaller forces
than the control condition at eight weeks (M=91.15
grams, SD=224.1). The sham control condition also
showed a change in SWME measures, but this change
was not statistically significant (t-test: t(7)=1.190;
p=0.254; signed-ranks: Z=-1.40; p>0.05). Figure 4
shows the trends in these values throughout the en-
tire study.
Modified Ashworth Scale (MAS)
Modified Ashworth Scale (MAS) was measured in a
clinical setting for flexion and extension of MCP/PIP
finger joints, thumb, wrist, elbow, and shoulder. Here,
results are reported for the fingers which showed the
most change in values. MAS values here are reported
on a scale of 0-5 and summed for the fingers. Starting
means (M=6.28, SD=2.16 for VTS; M=4.5, SD=1.46
for control) were compared using a Mann-Whitney U
test (U=16; z=1.63; p=0.052) and no significant dif-
ference was found. All users’ starting sums can be
found in Figure 5. Differences in experimental group
MAS were found to be significant using a Wilcoxon
signed-ranks test comparing starting measures to mea-
sures at 8 weeks (Z=-2.38; p<0.05). Average differ-
ence at 8 weeks was M=-2.94 total points on the Ash-
worth scale for the finger joints of the affected arm
for users in the VTS condition. Differences in control
group MAS at 8 weeks were also compared using the
Wilcoxon signed-ranks test (Z=-0.51; p>0.05) but the
difference (M=-0.53) was not considered significant.
Change from baseline was compared between condi-
tions and found to be significantly different (Mann-
Whitney: U=7.5; z=2.52; p=0.006). Participant 7 had
[2]Mean sum of force levels for the hand (sum of 20
points).
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Figure 5 Sum of Modified Ashworth values for the fingers at baseline and after eight weeks. MAS values here are reported on a
scale of 0-5. Lower scores are better.
severe spasticity before the study, which led to a Ba-
clofen pump and wrist fusion surgery. These inter-
ventions were failing to stop the progression of tone
and spasticity in their hand; however, their tone was
reduced after participation in the study. Two users
(5 and 7) agreed to follow-up six months post-study.
There was no significant relapse in values at follow-up
vs. study end.
Active Range of Motion (AROM)
Motor function was measured in a clinical setting as
the angular degrees of voluntary movement at joints
in the fingers and arm. Each of four body areas are
summed (i.e., voluntary angular motion for shoulder is
the sum of flexion, extension and abduction). Measures
are taken in the neutral gravity plane whenever pos-
sible. Compensation from other muscles and synergy
with spasticity are not included as voluntary range.
Finger and elbow extension is measured from a
flexed position, not from neutral, so as to report
voluntary extension that may be used for activities
such as releasing objects from grasp. Finger AROM
is measured at the MCP and PIP joints, and those
values are summed. Thus, “Finger Flex.” and “Finger
Ext.” include change in both the average MCP and
PIP ranges.
Starting means for arm motion and finger flexion had
a significant difference between conditions. The con-
trol group included fewer members with low to mod-
erate starting function. Baseline function may be a
factor in the results for the control group, but further
study is needed to examine its influence. The con-
trol group showed no significant difference in shoul-
der (M=202.9°, SD=135.0°, Avg.Change=2.7°), el-
bow (M=113.8°, SD=115.7°, Avg.Change=-2.9°), wrist
(M=48.6°, SD=38.9°, Avg.Change=3.0°), finger flexion
(M=25.0°, SD=31.3°, Avg.Change=50.9°) or finger ex-
tension range (M=10.9°, SD=18.1°, Avg.Change=57.2°).
The experimental VTS condition showed improve-
ments in sum of shoulder (M=63.5°, SD=66.7°, Avg.
Change=44.6°), elbow (M=54.1°, SD=52.5°, Avg.Change
=69.5°), and sum of finger flexion (M=117.8°, SD=71.9°,
Avg. Change=10.6°) range of motion. A Wilcoxon
signed-ranks test found these changes to be significant
(Z=-2.20, -2.03, -2.20, p<0.05), and this finding was
consistent with a paired t-test (t(7)=2.59, 2.98, 2.16,
p=0.018, 0.010, 0.033). Change in range of motion for
the wrist (M=9.5°, SD=12.5°, Avg. Change=16.5°) and
finger extension (M=46.3°, SD=52.0°, Avg.Change=20.7°)
was not found to be statistically significant. Changes
in voluntary ROM are shown in Figure 6.
Discussion
Participants who received vibrotactile stimulation
showed significant change in measures whereas those
in the control group did not. The wearable devices suc-
cessfully delivered mobile stimulation throughout the
duration of the study, and all participants were able
to adhere to the daily wearing protocol.
Changes in SWME measures suggest that partici-
pants showed improved tactile perception. Figure 4
suggests that the trend in improvement was gradual.
One participant reported the return of protective sen-
sation in cases of joint hyper-extension, and one re-
ported being able to feel the vibrations when they
could not initially.
Some participants in the VTS condition provided
observations that the affected hand was more open
and flexible. These observations were consistent with
changes in Modified Ashworth Scale measures. Fig-
ure 5 shows each person’s starting and ending mea-
sures. All but one person in the experimental condi-
tion showed a reduction in MAS values. Participants
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Figure 6 Increase in angular degrees of voluntary movement for four upper body locations between baseline and study end.
Shoulder, elbow and wrist values include both flexion and extension (from flexed) ranges. Finger flexion and extension is shown
separately to provide greater detail, and these values include both MCP and PIP ranges. Zero values most often occurred when the
participant had no voluntary movement in the joint at baseline and eight weeks.
in both conditions must frequently stretch open their
affected hand to don the device, and stretching may
be associated with changes in MAS. However, partici-
pants in the control group (who also stretched to don
the device daily) did not show a significant change in
MAS values, which suggests that stimulation rather
than stretching is associated with these changes. Tone
and spasticity lack effective or lasting treatment op-
tions, yet 40-50% of stroke survivors with upper ex-
tremity disability may be affected [38, 39] . More
study is needed, but this promising preliminary evi-
dence along with that in prior work suggests that af-
ferent stimulation may be used to address spasticity
and tone. The VTS Glove allows extended stimula-
tion and further study of this technique. Future work
can adjust stimulation characteristics to target differ-
ent sensory receptors and examine optimal settings.
Some participants with flexed fingers struggled to don
the glove device, so the design was subsequently re-
vised for accessibility.
Changes in voluntary range of motion may be due
in part to reduction in involuntary tone. Some par-
ticipants showed large increases in range, with near-
normal finger extension and flexion at week eight. Oth-
ers showed no change in voluntary range of motion.
Further study can provide details on what markers,
such as initial motor ability, predict outcomes using
this device. Some changes were found in the elbow and
shoulder, which may be due stimulation to or other fac-
tors. Vibration can be widely conducted throughout
the human body via bones and other tissues [40, 41].
Future work should examine if these results are
maintained, but the informal follow-ups that were ac-
cepted by the two participants suggest that improve-
ments may be lasting. Some participants had their
stroke many years ago, and demonstrated change in
measures. Participants used the device for over 160
hours each, an intensity enabled by the wearable form
factor and the passive stimulation method. In line with
this result, a body of research has previously associated
rehabilitation intensity (practice time) with improved
outcomes [42, 43, 44]. Participants in the experimen-
tal condition reported new capabilities on the weekly
worksheet that included helping to cook, cleaning their
hobby equipment, donning winter gloves and holding
their partner’s hand. They also reported new tactile
perception from the hand including sensing the vibra-
tions, hyperextension during stretching, and the spray
of water. Three participants reported a greater sense
of embodiment or ownership of the limb. Participants
took advantage of the mobile nature of the device: re-
porting wearing the device to events such as church,
lunch, and the movies.
Study limitations
This investigation intends to establish the feasibility
of wearable vibrotactile stimulation to improve dimin-
ished limb function. Participants include various lev-
els of disability, which provides initial data on who
may be suited for this stimulation. The Modified Ash-
worth Scale is a standard measure of tone and spas-
ticity, but there are confounding factors for this mea-
sure. These factors were controlled whenever possible
including arm position, time of day, and rater.
Effects of the Control Condition
Some change in measures may be expected when using
the sham device. The sham device provided cutaneous
sensory stimulation via the fabric of the glove; while
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the VTS experimental device provided additional cu-
taneous, and proprioceptive, stimulation via vibra-
tion. Furthermore, both conditions encouraged atten-
tion and engagement with the limb. However, in con-
trast to the experimental group, the control group did
not show significant changes.
Possible Mechanisms Behind Changes in Limb Function
A wearable device can facilitate engagement with the
disabled limb, which may help discourage maladaptive
plastic changes from sensory deprivation and learned
non-use. Learned non-use [45, 46, 47] is thought to be
one of the reasons behind limited functional improve-
ment of limbs after stroke: survivors learn to compen-
sate and do not force themselves to re-learn the use
of their limb. In addition, participants stretched open
their affected hand to don and doff the device several
times per day. This stretching was expected to impact
Modified Ashworth measures. Lesion location was not
recorded in the study, but this information would pro-
vide interesting additional data if recorded in future
work.
The control condition allowed us to examine the im-
pacts of these mechanisms. All participants interacted
with a wearable device, but the experimental VTS
group showed significantly different clinical measures
after eight weeks. This difference suggests that engage-
ment and stretching may not be the only mechanisms
to influence the participants.
Changes in tactile perception may be due central
mechanisms. Afferent input, transmitted by intact pe-
ripheral nervous pathways, may activate central ner-
vous system regions. This sensory input could impact
central organization as is found in constraint-induced
movement therapy after brain injury, or during normal
sensorimotor skill acquisition [48, 46, 49].
Vibration may help regulate electrophysiology asso-
ciated with spasticity via afferent feedback. Reduced
threshold of the stretch reflex has been implicated as
one of the mechanisms behind symptoms of spastic-
ity [50, 51]. Supraspinal control usually regulates this
reflex, but can be disrupted in events such as spinal
cord injury or stroke [50]. These reflexes are also medi-
ated by afferent feedback produced during limb move-
ment [52, 53]. Vibration provides similar feedback –
like many small muscle stretches – activating cuta-
neous mechanoreceptors and proprioceptive afferents
[54, 55]. Afferent feedback then may induce reflex sup-
pression and involuntary muscle contraction – which
may impact spasticity and are found during whole
body vibration (WBV) and focal muscle/tendon vi-
bration [25, 26, 31, 27, 56]. Presynaptic inhibition
from afferent discharge is cited as a possible mech-
anism underlying reflex suppression during vibration
[33]. Continuous passive motion is another treatment
for spasticity, but removal of proprioceptive afferents
was shown to prevent normalization [52, 57] suggest-
ing that sensory feedback may underlie this method.
Investigation of these factors is beyond the scope of
this work, but the promising results warrant further
study.
Improved voluntary range of motion may be un-
locked when spasticity and tone decreases. Another
hypothesis for changes in voluntary motion is that such
sensory stimulation provides excitatory feedback and
coactivation of motor systems, and helps restore so-
matosensation useful in motor function [22, 58, 59, 60].
This hypothesis is supported by work in sensory stim-
ulation for motor learning and performance [61], and
motor rehabilitation [62, 63, 64, 65].
Conclusions
A controlled, randomized trial of 16 participants eval-
uated the feasibility of a wearable vibrotactile stimula-
tion method to reduce upper limb disability in chronic
stroke. All users were assigned to wear a computerized
glove on their affected hand for three hours per day.
Users in the sham control group received no stimula-
tion and those in the experimental condition received
vibrotactile stimulation from the glove.
The wireless, wearable device was used during daily
life, not in a clinical setting. Participants who re-
ceived vibrotactile stimulation demonstrated a signif-
icant change in measures of tactile perception, volun-
tary motion, and spasticity after eight weeks. Some
participants reported increase in protective sensation,
sense of embodiment, and return to activities of daily
living such as cleaning, cooking and writing using their
disabled hand.
Declarations
Ethical Approval and Consent to participate
This study was approved and overseen by the Office of Research
Integrity’s IRB board for the Georgia Institute of Technology. All
participants were screened using the Mini Mental State Exam (MMSE)
and provided written consent before beginning the study.
Consent for publication
Not Applicable.
Availability of supporting data
Not Applicable.
Competing interests
The authors declare that they have no competing interests.
Funding
This research was supported, in part, by the National Science
Foundation (NSF) Graduate Research Fellowship program, a grant from
the Georgia Tech Graphics, Visualization and Usability (GVU)
consortium, and a Microsoft Research PhD Fellowship.
Seim et al. Page 9 of 10
Authors’ contributions
All authors contributed to the study design and methodology. CES
designed and fabricated the devices used in the research, recruited
participants, and interfaced with clinicians. All authors drafted, edited,
and approved the final manuscript.
Acknowledgements
We would like to acknowledge and thank the other advisors to the
project: Edelle Field-Fote (Shepherd Center/Emory University/Georgia
Tech), Sarah Callahan (Shepherd Center) and Samir Belagaje (Emory
University/Grady Hospital Stroke and Neuroscience Center). Thanks
also to the clinicians of PT Solutions Midtown Atlanta and Physio Clinic
Midtown Atlanta for taking measurements in this study.
Author details
1 Stanford University, Department of Mechanical Engineering, Stanford,
CA, USA. 2 Emory University School of Medicine, Department of
Rehabilitation Medicine, Atlanta, GA, USA. 3 Georgia Institute of
Technology, College of Computing, Atlanta, CA, USA.
References
1. Bonita, R., Mendis, S., Truelsen, T., Bogousslavsky, J., Toole, J.,
Yatsu, F.: The global stroke initiative. The Lancet Neurology 3(7),
391–393 (2004)
2. Prevalence of stroke–united states, 2006-2010. Centers for Disease
Control and Prevention (CDC and others). Morbidity and Mortality
Weekly Report 61(20), 379 (2012)
3. Adamson, J., Beswick, A., Ebrahim, S.: Is stroke the most common
cause of disability? Journal of Stroke and Cerebrovascular Diseases
13(4), 171–177 (2004)
4. Wade, D., Langton-Hewer, R., Wood, V., Skilbeck, C., Ismail, H.:
The hemiplegic arm after stroke: measurement and recovery. Journal
of Neurology, Neurosurgery & Psychiatry 46(6), 521–524 (1983)
5. Parker, V., Wade, D., Hewer, R.L.: Loss of arm function after
stroke: measurement, frequency, and recovery. International
rehabilitation medicine 8(2), 69–73 (1986)
6. Connell, L.A., Lincoln, N., Radford, K.: Somatosensory impairment
after stroke: frequency of different deficits and their recovery.
Clinical rehabilitation 22(8), 758–767 (2008)
7. Tyson, S.F., Hanley, M., Chillala, J., Selley, A.B., Tallis, R.C.:
Sensory loss in hospital-admitted people with stroke: characteristics,
associated factors, and relationship with function.
Neurorehabilitation and Neural Repair 22(2), 166–172 (2008)
8. Feldman, D.E., Brecht, M.: Map plasticity in somatosensory cortex.
Science 310(5749), 810–815 (2005)
9. Van der Loos, H., Woolsey, T.A.: Somatosensory cortex: structural
alterations following early injury to sense organs. Science
179(4071), 395–398 (1973)
10. Buonomano, D.V., Merzenich, M.M.: Cortical plasticity: from
synapses to maps. Annual review of neuroscience 21(1), 149–186
(1998)
11. Xerri, C., Merzenich, M.M., Peterson, B.E., Jenkins, W.: Plasticity
of primary somatosensory cortex paralleling sensorimotor skill
recovery from stroke in adult monkeys. Journal of neurophysiology
79(4), 2119–2148 (1998)
12. Jablonka, J., Burnat, K., Witte, O., Kossut, M.: Remapping of the
somatosensory cortex after a photothrombotic stroke: dynamics of
the compensatory reorganization. Neuroscience 165(1), 90–100
(2010)
13. Bird, T., Choi, S., Goodman, L., Schmalbrock, P., Nichols-Larsen,
D.S.: Sensorimotor training induced neural reorganization after
stroke: a case series. Journal of neurologic physical therapy: JNPT
37(1), 27 (2013)
14. Pleger, B., Schwenkreis, P., Dinse, H.R., Ragert, P., Höffken, O.,
Malin, J.-P., Tegenthoff, M.: Pharmacological suppression of plastic
changes in human primary somatosensory cortex after motor
learning. Experimental brain research 148(4), 525–532 (2003)
15. Porter, L.L.: Patterns of projections from area 2 of the sensory
cortex to area 3a and to the motor cortex in cats. Experimental
brain research 91(1), 85–93 (1992)
16. Mattay, V.S., Callicott, J.H., Bertolino, A., Santha, A.K.,
Van Horn, J.D., Tallent, K.A., Frank, J.A., Weinberger, D.R.:
Hemispheric control of motor function: a whole brain echo planar
fmri study. Psychiatry Research: Neuroimaging 83(1), 7–22 (1998)
17. Dewald, J.A., Given, J., Rymer, W.Z.: Long-lasting reductions of
spasticity induced by skin electrical stimulation. IEEE Transactions
on Rehabilitation Engineering 4(4), 231–242 (1996)
18. Schabrun, S.M., Hillier, S.: Evidence for the retraining of sensation
after stroke: a systematic review. Clinical rehabilitation 23(1),
27–39 (2009)
19. Dimitrijevic, M.M., Stokié, D.S., Wawro, A.W., Wun, C.-C.C.:
Modification of motor control of wrist extension by mesh-glove
electrical afferent stimulation in stroke patients. Archives of
physical medicine and rehabilitation 77(3), 252–258 (1996)
20. Smith, P.S., Dinse, H.R., Kalisch, T., Johnson, M., Walker-Batson,
D.: Effects of repetitive electrical stimulation to treat sensory loss in
persons poststroke. Archives of physical medicine and rehabilitation
90(12), 2108–2111 (2009)
21. Tu-Chan, A.P., Natraj, N., Godlove, J., Abrams, G., Ganguly, K.:
Effects of somatosensory electrical stimulation on motor function
and cortical oscillations. Journal of neuroengineering and
rehabilitation 14(1), 113 (2017)
22. Cordo, P., Lutsep, H., Cordo, L., Wright, W.G., Cacciatore, T.,
Skoss, R.: Assisted movement with enhanced sensation (ames):
coupling motor and sensory to remediate motor deficits in chronic
stroke patients. Neurorehabilitation and neural repair 23(1), 67–77
(2009)
23. Estes, L.T., Backus, D., Starner, T.: A wearable vibration glove for
improving hand sensation in persons with spinal cord injury using
passive haptic rehabilitation. In: 2015 9th International Conference
on Pervasive Computing Technologies for Healthcare
(PervasiveHealth), pp. 37–44 (2015). IEEE
24. Enders, L.R., Hur, P., Johnson, M.J., Seo, N.J.: Remote vibrotactile
noise improves light touch sensation in stroke survivors’ fingertips
via stochastic resonance. Journal of neuroengineering and
rehabilitation 10(1), 105 (2013)
25. Abercromby, A.F., Amonette, W.E., Layne, C.S., Mcfarlin, B.K.,
Hinman, M.R., Paloski, W.H.: Variation in neuromuscular responses
during acute whole-body vibration exercise. Medicine & Science in
Sports & Exercise 39(9), 1642–1650 (2007)
26. Delecluse, C., Roelants, M., Verschueren, S.: Strength increase
after whole-body vibration compared with resistance training.
Medicine & Science in Sports & Exercise 35(6), 1033–1041 (2003)
27. Ness, L.L., Field-Fote, E.C.: Effect of whole-body vibration on
quadriceps spasticity in individuals with spastic hypertonia due to
spinal cord injury. Restorative neurology and neuroscience 27(6),
623–633 (2009)
28. Pang, M., Lau, R., Yip, S.: The effects of whole-body vibration
therapy on bone turnover, muscle strength, motor function, and
spasticity in chronic stroke: a randomized controlled trial. European
journal of physical and rehabilitation medicine 49(4), 439–450
(2013)
29. Binder, C., Kaya, A.E., Liepert, J.: Vibration prolongs the cortical
silent period in an antagonistic muscle. Muscle & Nerve: Official
Journal of the American Association of Electrodiagnostic Medicine
39(6), 776–780 (2009)
30. Kossev, A., Siggelkow, S., Kapels, H.-H., Dengler, R., Rollnik, J.:
Crossed effects of muscle vibration on motor-evoked potentials.
Clinical neurophysiology 112(3), 453–456 (2001)
31. Marconi, B., Filippi, G.M., Koch, G., Giacobbe, V., Pecchioli, C.,
Versace, V., Camerota, F., Saraceni, V.M., Caltagirone, C.:
Long-term effects on cortical excitability and motor recovery
induced by repeated muscle vibration in chronic stroke patients.
Neurorehabilitation and neural repair 25(1), 48–60 (2011)
32. Noma, T., Matsumoto, S., Shimodozono, M., Etoh, S., Kawahira,
K.: Anti-spastic effects of the direct application of vibratory stimuli
to the spastic muscles of hemiplegic limbs in post-stroke patients: a
proof-of-principle study. Journal of rehabilitation medicine 44(4),
325–330 (2012)
33. Rittweger, J.: Vibration as an exercise modality: how it may work,
and what its potential might be. European journal of applied
physiology 108(5), 877–904 (2010)
34. Siggelkow, S., Kossev, A., Schubert, M., Kappels, H.-H., Wolf, W.,
Seim et al. Page 10 of 10
Dengler, R.: Modulation of motor evoked potentials by muscle
vibration: the role of vibration frequency. Muscle & Nerve: Official
Journal of the American Association of Electrodiagnostic Medicine
22(11), 1544–1548 (1999)
35. Steyvers, M., Levin, O., Verschueren, S., Swinnen, S.:
Frequency-dependent effects of muscle tendon vibration on
corticospinal excitability: a tms study. Experimental brain research
151(1), 9–14 (2003)
36. Seim, C.: Wearable vibrotactile stimulation: How passive
stimulation can train and rehabilitate. PhD thesis, Georgia Institute
of Technology (2019)
37. Johnson, K.O.: The roles and functions of cutaneous
mechanoreceptors. Current opinion in neurobiology 11(4), 455–461
(2001)
38. Dajpratham, P., Kuptniratsaikul, V., Kovindha, A., Kuptniratsaikul,
P.S.-a., Dejnuntarat, K.: Prevalence and management of poststroke
spasticity in thai stroke patients: a multicenter study. Medical
journal of the Medical Association of Thailand 92(10), 1354 (2009)
39. Watkins, C., Leathley, M., Gregson, J., Moore, A., Smith, T.,
Sharma, A.: Prevalence of spasticity post stroke. Clinical
rehabilitation 16(5), 515–522 (2002)
40. Matsumoto, Y., Griffin, M.: Dynamic response of the standing
human body exposed to vertical vibration: influence of posture and
vibration magnitude. Journal of Sound and Vibration 212(1),
85–107 (1998)
41. Gurram, R., Rakheja, S., Gouw, G.J.: Vibration transmission
characteristics of the human hand-arm and gloves. International
Journal of Industrial Ergonomics 13(3), 217–234 (1994)
42. Teasell, R., Bitensky, J., Salter, K., Bayona, N.A.: The role of
timing and intensity of rehabilitation therapies. Topics in stroke
rehabilitation 12(3), 46–57 (2005)
43. Kwakkel, G.: Impact of intensity of practice after stroke: issues for
consideration. Disability and rehabilitation 28(13-14), 823–830
(2006)
44. Jette, D.U., Warren, R.L., Wirtalla, C.: The relation between
therapy intensity and outcomes of rehabilitation in skilled nursing
facilities. Archives of physical medicine and rehabilitation 86(3),
373–379 (2005)
45. Grant, V.M., Gibson, A., Shields, N.: Somatosensory stimulation to
improve hand and upper limb function after stroke—a systematic
review with meta-analyses. Topics in stroke rehabilitation 25(2),
150–160 (2018)
46. Liepert, J., Miltner, W., Bauder, H., Sommer, M., Dettmers, C.,
Taub, E., Weiller, C.: Motor cortex plasticity during
constraint-induced movement therapy in stroke patients.
Neuroscience letters 250(1), 5–8 (1998)
47. Wolf, S.L., Winstein, C.J., Miller, J.P., Taub, E., Uswatte, G.,
Morris, D., Giuliani, C., Light, K.E., Nichols-Larsen, D.,
Investigators, E., et al.: Effect of constraint-induced movement
therapy on upper extremity function 3 to 9 months after stroke: the
excite randomized clinical trial. Jama 296(17), 2095–2104 (2006)
48. Schaechter, J.D., Kraft, E., Hilliard, T.S., Dijkhuizen, R.M.,
Benner, T., Finklestein, S.P., Rosen, B.R., Cramer, S.C.: Motor
recovery and cortical reorganization after constraint-induced
movement therapy in stroke patients: a preliminary study.
Neurorehabilitation and neural repair 16(4), 326–338 (2002)
49. Liepert, J., Bauder, H., Miltner, W.H., Taub, E., Weiller, C.:
Treatment-induced cortical reorganization after stroke in humans.
Stroke 31(6), 1210–1216 (2000)
50. Dietz, V., Sinkjaer, T.: Spasticity. In: Handbook of Clinical
Neurology vol. 109, pp. 197–211. Elsevier, ??? (2012)
51. Powers, R., Marder-Meyer, J., Rymer, W.: Quantitative relations
between hypertonia and stretch reflex threshold in spastic
hemiparesis. Annals of Neurology: Official Journal of the American
Neurological Association and the Child Neurology Society 23(2),
115–124 (1988)
52. Lynskey, J.V., Belanger, A., Jung, R.: Activity-dependent plasticity
in spinal cord injury. Journal of rehabilitation research and
development 45(2), 229 (2008)
53. Sheean, G.: The pathophysiology of spasticity. European journal of
neurology 9, 3–9 (2002)
54. Burke, D., Hagbarth, K.-E., Löfstedt, L., Wallin, B.G.: The
responses of human muscle spindle endings to vibration of
non-contracting muscles. The Journal of physiology 261(3),
673–693 (1976)
55. Fallon, J.B., Macefield, V.G.: Vibration sensitivity of human muscle
spindles and golgi tendon organs. Muscle & Nerve: Official Journal
of the American Association of Electrodiagnostic Medicine 36(1),
21–29 (2007)
56. Noma, T., Matsumoto, S., Etoh, S., Shimodozono, M., Kawahira,
K.: Anti-spastic effects of the direct application of vibratory stimuli
to the spastic muscles of hemiplegic limbs in post-stroke patients.
Brain Injury 23(7-8), 623–631 (2009)
57. Ollivier-Lanvin, K., Keeler, B.E., Siegfried, R., Houlé, J.D., Lemay,
M.A.: Proprioceptive neuropathy affects normalization of the
h-reflex by exercise after spinal cord injury. Experimental neurology
221(1), 198–205 (2010)
58. Doyle, S., Bennett, S., Fasoli, S.E., McKenna, K.T.: Interventions
for sensory impairment in the upper limb after stroke. Cochrane
Database of Systematic Reviews (6) (2010)
59. Platz, T.: Impairment-oriented training (iot)–scientific concept and
evidence-based treatment strategies. Restorative neurology and
neuroscience 22(3-5), 301–315 (2004)
60. Raghavan, P.: The nature of hand motor impairment after stroke
and its treatment. Current treatment options in cardiovascular
medicine 9(3), 221–228 (2007)
61. Rosenkranz, K., Rothwell, J.C.: Differential effect of muscle
vibration on intracortical inhibitory circuits in humans. The Journal
of physiology 551(2), 649–660 (2003)
62. Cordo, P., Wolf, S., Lou, J.-S., Bogey, R., Stevenson, M., Hayes, J.,
Roth, E.: Treatment of severe hand impairment following stroke by
combining assisted movement, muscle vibration, and biofeedback.
Journal of Neurologic Physical Therapy 37(4), 194–203 (2013)
63. Forner-Cordero, A., Steyvers, M., Levin, O., Alaerts, K., Swinnen,
S.P.: Changes in corticomotor excitability following prolonged
muscle tendon vibration. Behavioural brain research 190(1), 41–49
(2008)
64. Golaszewski, S.M., Bergmann, J., Christova, M., Kunz, A.B.,
Kronbichler, M., Rafolt, D., Gallasch, E., Staffen, W., Trinka, E.,
Nardone, R.: Modulation of motor cortex excitability by different
levels of whole-hand afferent electrical stimulation. Clinical
Neurophysiology 123(1), 193–199 (2012)
65. Kaelin-Lang, A., Luft, A.R., Sawaki, L., Burstein, A.H., Sohn, Y.H.,
Cohen, L.G.: Modulation of human corticomotor excitability by
somatosensory input. The Journal of physiology 540(2), 623–633
(2002)
